IPW
VRTX icon

Impact Partnership Wealth’s Vertex Pharmaceuticals VRTX Stock Holding History

Impact Partnership Wealth’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$206K Sell
461
-19
-4% -$8.86K 0.03% 341
2025
Q4 		$218K Buy
+480
New +$207K 0.03% 330
2024
Q2 		– Sell
-828
Closed -$346K – 675
2024
Q1 		$346K Buy
828
+16
+2% +$6.76K 0.14% 109
2023
Q4 		$330K Sell
812
-197
-20% -$72.8K 0.12% 111
2023
Q3 		$351K Buy
+1,009
New +$353K 0.11% 107

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Impact Partnership Wealth's VRTX Position: Q1 2026 in Review

Impact Partnership Wealth reduced its Vertex Pharmaceuticals (VRTX) stake by 4% in Q1 2026, selling an estimated $8.86K and leaving 461 shares worth $206K. The position accounts for 0.03% of the portfolio, ranked #341.

Impact Partnership Wealth first reported a position in VRTX in Q3 2023 and has held it in 5 quarters since. The position peaked at $351K in Q3 2023. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Impact Partnership Wealth held 461 shares of Vertex Pharmaceuticals worth $206K as of Q1 2026.
  • Impact Partnership Wealth sold 19 Vertex Pharmaceuticals shares in Q1 2026, an estimated $8.86K.
  • Vertex Pharmaceuticals made up 0.03% of Impact Partnership Wealth's portfolio in Q1 2026, its #341 holding.
  • Impact Partnership Wealth first reported a position in Vertex Pharmaceuticals in Q3 2023 and has held it in 5 quarters since.
  • Impact Partnership Wealth's Vertex Pharmaceuticals position peaked at $351K in Q3 2023.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Impact Partnership Wealth's 13F filing for Q1 2026, filed 23 Apr 2026.